Abstract
HIV+ subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors (PIs). We found that in humans and mice, PIs do not affect antibody production in response to pneumococcal vaccination.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 524-529 |
| Number of pages | 6 |
| Journal | Clinical and Vaccine Immunology |
| Volume | 23 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2016 |
| Externally published | Yes |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Clinical Biochemistry
- Microbiology (medical)
Fingerprint
Dive into the research topics of 'Protease inhibitors do not affect antibody responses to pneumococcal vaccination'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS